Expert Advisory: Pharmacists Comment On FDA Approval Of Non-Opioid Pain Killer, Journavx
The FDA recently approved use of the drug, Journavx, as a pain killer alternative to opioids. The first new pain killer approved in 25 years by the agency, it gives patients an opioid-free option reducing the risk of addiction. Drs. Jacqueline Cleary and Amanda Engle, pharmacists from Albany College of Pharmacy and Health Sciences, are available to offer insight on this new drug approval. As pharmacists embedded in the community, they know the drug well and understand its ramifications.
Read More
Social